Principal Financial Group
MCRB icon

Principal Financial Group’s Seres Therapeutics MCRB Stock Holding History

Principal Financial Group’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-536
Closed -$7.76K – 2333
2024
Q2 		$7.76K Sell
536
-818
-60% -$13.6K ﹤0.01% 2360
2024
Q1 		$21K Sell
1,354
-1,729
-56% -$37.3K ﹤0.01% 2404
2023
Q4 		$86.3K Buy
3,083
+386
+14% +$10.1K ﹤0.01% 2282
2023
Q3 		$128K Buy
2,697
+437
+19% +$33.3K ﹤0.01% 2243
2023
Q2 		$217K Buy
2,260
+400
+22% +$43.5K ﹤0.01% 2163
2023
Q1 		$211K Sell
1,860
-223
-11% -$24.1K ﹤0.01% 2169
2022
Q4 		$233K Buy
2,083
+1,039
+100% +$139K ﹤0.01% 2159
2022
Q3 		$134K Sell
1,044
-18
-2% -$1.84K ﹤0.01% 2273
2022
Q2 		$73K Sell
1,062
-91
-8% -$7.84K ﹤0.01% 2432
2022
Q1 		$164K Buy
1,153
+16
+1% +$2.46K ﹤0.01% 2366
2021
Q4 		$189K Sell
1,137
-520
-31% -$82.6K ﹤0.01% 2379
2021
Q3 		$230K Sell
1,657
-1,219
-42% -$239K ﹤0.01% 2393
2021
Q2 		$1.37M Sell
2,876
-53
-2% -$22.4K ﹤0.01% 1981
2021
Q1 		$1.21M Buy
2,929
+1,308
+81% +$602K ﹤0.01% 1953
2020
Q4 		$795K Buy
1,621
+1,220
+304% +$714K ﹤0.01% 1994
2020
Q3 		$227K Buy
+401
New +$133K ﹤0.01% 2179

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Principal Financial Group's MCRB Position: Q3 2024 in Review

Principal Financial Group sold out of Seres Therapeutics (MCRB) in Q3 2024, closing a stake of 536 shares — an estimated $7.76K sold.

Principal Financial Group first reported a position in MCRB in Q3 2020 and held it in 16 quarters. The position peaked at $1.37M in Q2 2021. 77 funds tracked by Wall St. Rank hold MCRB as of Q3 2024.

  • Principal Financial Group reported no remaining Seres Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Principal Financial Group sold 536 Seres Therapeutics shares in Q3 2024, an estimated $7.76K.
  • Principal Financial Group first reported a position in Seres Therapeutics in Q3 2020 and held it in 16 quarters.
  • Principal Financial Group's Seres Therapeutics position peaked at $1.37M in Q2 2021.
  • 77 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2024.

Based on Principal Financial Group's 13F filing for Q3 2024, filed 31 Oct 2024.